Structural characterization of two polymorphic forms of piroxicam pivalate

Journal of Pharmaceutical Sciences

Volumn 87, Issue 12, 1998, Pages 1608-1614

  Caira, Mino R ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; HYDROGEN; NITROGEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PIROXICAM PIVALATE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; DRUG STRUCTURE; HYDROGEN BOND; X RAY DIFFRACTION;

EID: 0031773643     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980059s     Document Type: Article

References (19)

1. Reck, G.; Dietz, G.; Laban, G.; Guenther, W.; Bannier, G.; Hoehne, E. X-ray Studies on Piroxicam Modifications. Pharmazie 1988, 43, 477-481.
2. Kojic-Prodic, B.; Ruzic-Toros, Z. Structure of the Antiinflammatory Drug 4-Hydroxy-2-methyl-N-2-pvridyl-2//-U6,2-benzothiazine-3-carboxamide-1,1 -Dioxide (Piroxicam). Acta Crystallogr. 1982, B38, 2948-2951.
3. Bordner, J.; Richards, J. A.; Weeks, P.; Whipple, E. B. Piroxicam Monohydrate: a Zwitterionic Form, CisHiaNsC-SH2O. Acta Crystallogr. 1984, C40, 989-990.
4. Caira, M. R.; Nassimbeni, L. R.; Timme, M. Zwitterionic Nature of Tenoxicam: Crystal Structure and Thermal Analyses of a Polymorph of Tenoxicam and a 1:1 Tenoxicam: Acetonitrile Solvate. J. Pharm. Sci. 1995, 84, 884-888.
5. Janik, M.; Malarski, Z.; Mrozinski, J.; Wajcht, J.; Zborucki, Z. Influence of Solvent Effect on Polymorphism of 4-Hydroxy2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide1,1-Dioxide (Piroxicam). J. Crystallogr. Spectrosc. Res. 1991, 21, 519-522.
6. Chérie Ligniere, G.; Montagnani, G.; Alberici, M.; Acerbi, D. Plasma and Synovial Fluid Concentrations of Piroxicam during Prolonged Treatment with Piroxicam Pivalic Ester. Arzneim. Forsch. 1987 37, 560-563.
7. Giordano F.; Gazzaniga, A.; Moyano, J. R.; Ventura, P.; Zanol, M.; Peveri, T.; Carima, L. Crystal Forms of Piroxicam Pivalate: Preparation and Characterization of Two Polymorphs. J. Pharm. Sci. 1998, 87, 333-337.
8. Yu, L. Inferring Thermodynamic Stability Relationship of Polymorphs from Melting Data. J. Pharm. Sci. 1995, 84, 966-974.
9. Li, Z. J.; Grant, D. J. W. Relationship Between Physical Properties and Crystal Structures of Chiral Drugs. J. Pharm. Sci. 1997, 86, 1073-1078.
10. Stephenson, G. A.; Stowell, J. G.; Toma, P. H.; Pfeiffer, R. R.; Byrn, S. R. Solid-state Investigations of Erythromycin A Dihydrate: Structure, NMR Spectroscopy, and Hygroscopicity. J. Pharm. Sci. 1997, 86, 1239-1244.
11. Bernstein, J. Crystal Growth, Polymorphism and Structureproperty Relationships in Organic Crystals. J. Phys. D: Appl. Phys. 1993, 26, B66-B76.
12. Frenz, B. A., and Associates Inc. 1982, Structure Determination Package (College Station, TX).
13. Sheldrick, G. M. SHELXS-86. In Crystallographic Computing 3; Sheldrick, G. M., Kruger, C., Goddard, R., Eds.; Oxford University: 1985; pp 175-178.
14. Sheldrick, G. M. SHELX-76, Program for Crystal Structure Determination; University of Cambridge: Cambridge, UK, 1976.
15. Yvon, K.; Jeitschko, W.; Parthe, E. J. LAZY PULVERIX, a Computer Program, for Calculating X-ray and Neutron Diffraction Powder Patterns. J. Appl. Crystallogr. 1977, 10, 73-74.
16. Zsolnai, L.; Pritzkow, H. ZORTEP: Ortep Program for Personal Computer, University of Heidelberg, Germany, 1994.
17. Bar, L; Bernstein, J. Conformational Polymorphism VI: The Crystal and Molecular Structures of Form II, Form III, and Form V of 4-amino-N-2-pyridinylbenzenesulfonamide (Sulfapyridine). J. Pharm. Sci. 1985, 74, 255-263.
18. Chiesi internal report, unpublished results.
19. Gavezzotti, A.; Filippini, G. Computer Prediction of Organic Crystal Structures Using Partial X-ray Diffraction Data. J. Am. Chem. Soc. 1996, 118, 7153-7157.